Patents by Inventor Beate Katz

Beate Katz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions of tolperisone
    Patent number: 9675598
    Abstract: The present disclosure relates to tolperisone, or a pharmaceutically acceptable salt or hydrate thereof, with 10 ppm 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) or less, methods of producing the same, as well as compositions related thereto. The disclosure further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO.
    Type: Grant
    Filed: August 1, 2016
    Date of Patent: June 13, 2017
    Assignee: Sanochemia Pharmazeutika AG
    Inventors: Federico Gaeta, Klaus Gerdes, Stefan Welzig, Beate Katz, Jan Rothenburger, Jozsef Gungl
  • Methods of administering tolperisone for therapeutic purposes
    Patent number: 9662317
    Abstract: The present disclosure relates to methods of administering tolperisone to subjects in need thereof. In certain aspects, the present disclosure relates to methods of administering tolperisone to subjects in need thereof, said methods limiting the exposure of the subject to 4-MMPPO.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: May 30, 2017
    Assignee: SANOCHEMIA PHARMAZEUTIKA AG
    Inventors: Federico Gaeta, Klaus Gerdes, Stefan Welzig, Beate Katz, Jan Rothenburger, Jozsef Gungl
  • COMPOSITIONS OF TOLPERISONE
    Publication number: 20160367540
    Abstract: The present disclosure relates to tolperisone, or a pharmaceutically acceptable salt or hydrate thereof, with 10 ppm 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) or less, methods of producing the same, as well as compositions related thereto. The disclosure further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO.
    Type: Application
    Filed: August 1, 2016
    Publication date: December 22, 2016
    Applicant: SANOCHEMIA PHARMAZEUTIKA AG
    Inventors: Federico Gaeta, Klaus Gerdes, Stefan Welzig, Beate Katz, Jan Rothenburger, Jozsef Gungl
  • METHODS OF ADMINISTERING TOLPERISONE FOR THERAPEUTIC PURPOSES
    Publication number: 20160220549
    Abstract: The present disclosure relates to methods of administering tolperisone to subjects in need thereof. In certain aspects, the present disclosure relates to methods of administering tolperisone to subjects in need thereof, said methods limiting the exposure of the subject to 4-MMPPO.
    Type: Application
    Filed: March 11, 2016
    Publication date: August 4, 2016
    Applicant: SANOCHEMIA PHARMAZEUTIKA AG
    Inventors: Federico Gaeta, Klaus Gerdes, Stefan Welzig, Beate Katz, Jan Rothenburger, Jozsef Gungl
  • COMPOSITIONS OF TOLPERISONE
    Publication number: 20100324090
    Abstract: The present disclosure is directed to methods for providing tolperisone having extremely low levels of 4-MMPPO (2-methyl-1-(4-methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features.
    Type: Application
    Filed: April 24, 2008
    Publication date: December 23, 2010
    Inventors: Federico Gaeta, Klaus Gerdes, Stefan Welzig, Beate Kätz, Jan Rothenburger, József Gungl